biotech

Revance Therapeutics Shares Jumped After Positive Top-Line Results From Phase 3 Trial

Revance Therapeutics Shares Jumped After Positive Top-Line Results From Phase 3 Trial

Revance Therapeutics Inc (NASDAQ: RVNC) is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions. On Tuesday shares of the Revance jumped about 10% a after the company announced its n..

Novartis buys Advanced Accelerator Applications for $3.9 billion

Novartis buys Advanced Accelerator Applications for $3.9 billion

Novartis AG (NYSE: NVS) has entered into a written agreement with French pharmaceutical company, Advanced Accelerator Applications (NASDAQ: AAAP), for $3.9 billion. Novartis shares were up 0.8 percent and Advanced Accelerator Applications shares wer..

Abbott Laboratories Announced Better-than-Expected Q3 Results

Abbott Laboratories Announced Better-than-Expected Q3 Results

On Wednesday, Abbott Laboratories (NYSE: ABT) announced its financial results for the third quarter of 2017, with both earnings and revenue beating estimates. Shares of the company increased 1.6% in morning trade on Wednesday.According to the compan..

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum Pharmaceutical Inc. (NASDAQ: SPPI) shares surged over 40 percent on Tuesday at open after its announcement of positive results from its Phase 2 clinical study of poziotinib. The announcement was presented at the 18th IASLC World Conference ..

Pfizer Considers the Sales of its Consumer Healthcare Business

Pfizer Considers the Sales of its Consumer Healthcare Business

On Tuesday, Pfizer Inc. (NYSE: PFE), the pharmaceutical giant, said that it is considering the sale or spin-off of its consumer healthcare business, whose brands include lip balm Chapstick and painkiller Advil.The company’s consumer healthcare..

Halozyme Therapeutics Stock Up After Partnership with Roche

Halozyme Therapeutics Stock Up After Partnership with Roche

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stock up more than 18% on Thursday after the biotechnology company announced that it has licensed its ENHANZE® drug-delivery technology to Roche for exclusive development of an undisclosed therapeutic t..

Bayer Partnership with Start-Up in Agri Niche

Bayer Partnership with Start-Up in Agri Niche

A partnership has been announced between German company Bayer and a biotech start-up based in Boston to enable crops to make their own fertilizer. The move which is expected to make waves in the agriculture sector will give substantial impetus to Bo..